Functions of cyclin A1 in the cell cycle and its interactions with transcription factor E2F-1 and the Rb family of proteins

Molecular and Cellular Biology

Volumn 19, Issue 3, 1999, Pages 2400-2407

  Yang, Rong ^a,d   Müller, Carsten ^a   Huynh, Vong ^a   Fung, Yuen K ^b   Yee, Amy S ^c   Koeffler, H Phillip ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CHILDREN S HOSPITAL LOS ANGELES   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN A; CYCLIN A1; CYCLIN A1 ASSOCIATED KINASE; PROTEIN P21; TRANSCRIPTION FACTOR E2F; TRANSCRIPTION FACTOR E2F1; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE; CELL CYCLE G2 PHASE; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; MITOSIS; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION REGULATION;

INSECTA;

EID: 0344196961     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.19.3.2400     Document Type: Article

References (43)

1. Akiyama, T., T. Ohuchi, S. Sumida, K. Matsumoto, and K. Toyoshima. 1992. Phosphorylation of the retinoblastoma protein hy CDK2. Proc. Natl. Acad. Sci. USA 89:7900-7904.
2. Becton Dickinson and Co. 1996. Becton Dickinson manual. Becton Dickinson and Co., Paramus, N.J.
3. Cao, L., B. Faha, M. Dembski, L.-H. Tsai, E. Harlow, and N. Dyson. 1992. Independent binding of the retinoblastoma protein and p107 to the transcription factor E2F. Nature 355:176-179.
4. Carbonaro-Hall, D., R. Williams, L. Wu, D. Warburton, M. Zeichner-David, M. MacDougall, V. Tolo, and F. Hall. 1993. G1 expression and multistage dynamics of cyclin A in human osteosarcoma cells. Oncogene 8:1649-1659.
5. Connell-Crowley, L., J. W. Harper, and D. W. Goodrich. 1997. Cyclin D1/ Cdk4 regulates retinoblastoma protein-mediated cell cycle arrest by site-specific phosphorylation. Mol. Biol. Cell 8:287-301.
6. cdk2 is a component of the E2F-cyclin A complex. Cell 68:167-176.
7. Dowdy, S. F., P. W. Hinds, K. Louie, S. I. Reed, A. Arnold, and R. A. Weinberg. 1993. Physical interaction of the retinoblastoma protein with human D cyclins. Cell 73:499-511.
8. Ewen, M. E., H. K. Sluss, C. J. Sherr, H. Matsushime, J. Kato, and D. M. Livingston. 1993. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell 73:487-497.
9. Ewen, M. E., B. Faha, E. Harlow, and D. M. Livingston. 1992. Interaction of p107 with cyclin A independent of complex formation with viral oncoproteins. Science 255:85-87.
10. Faha, B., M. E. Ewen, L.-H. Tsai, D. M. Livingston, and E. Harlow. 1992. Interaction between human cyclin A and adenovirus E1A-associated p107 protein. Science 255:87-90.
11. Fields, S., and O.-K. Song. 1989. A novel genetic system to detect protein-protein interactions. Nature 340:245-246.
12. Hall, M., S. Bates, and G. Peters. 1995. Evidence for different modes of action of cyclin-dependent kinase inhibitors: p15 and p16 bind to kinases. p21 and p27 bind to cyclins. Oncogene 11:1581-1588.
13. Harlow, E., and D. Lane. 1989. Antibodies: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
14. Hinds, P. W., S. Mittnacht, V. Dulic, A. Arnold, S. I. Reed, and R. A. Weinberg. 1992. Regulation of retinoblasloma protein functions by ectopic expression of human cyclins. Cell 70:993-1006.
15. Hirama, T., and H. P. Koeffler. 1995. Role of the cyclin-dependent kinase inhibitors in the development of cancer. Blood 86:841-854.
16. Howe, J. A., M. Howell, T. Hunt, and J. W. Newport. 1995. Identification of a developmental timer regulating the stability of embryonic cyclin A and a new somatic A-type cyclin at gastrulation. Genes Dev. 9:1164-1176.
17. Hu, Q., J. A. Lees, K. Buchkovich, and E. Harlow. 1992. The retinoblastoma protein physically associates with the human cdc2 kinase. Mol. Cell. Biol. 12:971-980.
18. Jackman, M. R., and J. N. Pines. 1997. Cyclins and the G2/M transition. Cancer Surv. 29:47-73.
19. Jiang, W., and T. Hunter. 1998. Analysis of cell-cycle profiles in transfected cells using a membrane-targeted GFP. BioTechniques 24:349-350.
20. Kato, J., H. Matsushime, S. Hiebert, M. E. Ewen, and C. J. Sherr. 1993. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev. 7:331-342.
21. Kitagawa, M., H. Higashi, H.-K. Jung, S. Suzuki-Takahashi, M. Ikeda, K. Tamai, J.-Y. Kato, K. Segawa, E. Yoshida, S. Nishimura, and Y. Taya. 1996. The consensus motif for phosphorylation by cyclin D1-cdk4 is different from that for phosphorylation by cyclin A/E-cdk2 EMBO J. 15:7060-7069.
22. Krek, W., M. E. Ewen, S. Shirodkar, Z. Arany, W. G. Kaelin, and D. Livingston. 1994. Negative regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinase. Cell 78:161-172.
23. Lacy, S., and P. Whyte. 1997. Identification of a p130 domain mediating interactions with cyclin A/cdk2 and cyclin E/cdk2 complexes. Oncogene 14:2395-2406.
24. Lees, J. A., K. J. Buchkovich, D. R. Marshak, C. W. Anderson, and E. Harlow. 1991. The retinoblastoma protein is phosphorylated on multiple sites by human cdc2. EMBO J. 10:4279-4290.
25. Li, Y., C. Graham, S. Lacy, A. M. V. Duncan, and P. Whyte. 1996. The adenovirus E1A-associated 130-KD protein is encoded by a member of the retinoblastoma gene family and physically interacts with cyclins A and E. Genes Dev. 7:2366-2377.
26. Lundberg, A. S., and R. A. Weinberg. 1998. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol. Cell. Biol. 18:753-761.
27. Morgan, D. O. 1995. Principles of CDK regulation. Nature 374:131-134.
28. Murphy, M., M. Stinnakre, C. Senamaud-Beaufort, N. J. Winston, C. Sweeney, M. Kubelka, M. Carrington, C. Brechot, and J. Sobczak-Thepot. 1997. Delayed early embryonic lethality following disruption of the murine cyclin A2 gene. Nat. Genet. 15:83-86.
29. Nevins, J. R., G. Leone, J. DeGregori, and L. Jakoi. 1997. Role of the Rb/E2F pathway in cell growth control. J. Cell. Physiol. 173:233-236.
30. Nurse, P. 1994. Ordering S phase and M phase in the cell cycle. Cell 79:547-550.
31. Pagano, M., R. Pepperkok, F. Verde, W. Ansorge, and G. Draetta. 1992. Cyclin A is required at two points in the human cell cycle. EMBO J. 11:961-971.
32. Reed, S. I. 1997. Control of the G1/S transition. Cancer Surv. 29:7-23.
33. Sherr, C. J. 1994. G1 phase progression: cycling on cue. Cell 79:551-555.
34. Sherr, C. J., and J. M. Roberts. 1995. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 9:1149-1163.
35. Sweeney, C., M. Murphy, M. Kubelka, S. E. Ravnik, C. F. Hawkins, D. J. Wolgemuth, and M. Carrington. 1996. A distinct cyclin A is expressed in germ cells in the mouse. Development 122:53-64.
36. Wang, J. Y. J., E. S. Knudsen, and P. J. Welch. 1994. The retinoblastoma tumor suppressor protein. Adv. Cancer Res. 64:25-85.
37. Weinberg, R. A. 1995. The retinoblastoma protein and cell cycle control. Cell 81:323-330.
38. Williams, R. T., D. A. Carbonaro-Hall, and F. L. Hall. 1992. Co-purification of p34cdc2/p58 cyclin A proline-directed protein kinase and the retinoblastoma tumor susceptibility gene product: interaction of an oncogenic serine/ threonine protein kinase with a tumor-suppressor protein. Oncogene 7:423-432.
39. Xu, M., K.-A. Sheppard, C.-Y. Peng, A. S. Yee, and H. Piwnica-Worms. 1994. Cyclin A/CDK2 binds directly to E2F-1 and inhibits the DNA-binding activity of E2F-1/DP-1 by phosphorylation. Mol. Cell. Biol. 14:8420-8431.
40. Yang, R., R. Morosetti, and H. P. Koeffler. 1997. Characterization of a second human cyclin A that is highly expressed in testis and in several leukemic cell lines. Cancer Res. 57:913-920.
41. Yang, R., and H. P. Koeffler. Unpublished data.
42. Zarkowska, T., and S. Mittnacht. 1997. Differential phosphorylation of the retinoblastoma protein by G1/S cyclin-dependent kinases. J. Biol. Chem. 272:12738-12746.
43. cip1-related domain to bind cyclin/cdk2 and regulate interactions with E2F. Genes Dev. 9:1740-1752.